demonstrated the involvement of CB1R in BP regulation: the CB1R antagonists SR141716A and AM251 aggravated HTN in SHR whereas URB597, an inhibitor of FAAH, reduced BP in SHR and in the chronic Ang II infusion induced HTN (151). The gene discussed is AGT; the disease is hypertensive disorder.